Adding MS drug to t...
 
Notifications
Clear all

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

1 Posts
1 Users
2 Likes
1,518 Views
(@j)
Joined: 6 years ago
Posts: 2160
Topic starter  

"When treated with both teriflunomide and BKM-120, tumours shrank markedly on average and the mice survived significantly longer, compared to mock-treated mice or mice who received either treatment alone."

https://ecancer.org/news/16443-adding-ms-drug-to-targeted-cancer-therapy-may-improve-glioblastoma-outcomes.php


   
Daniel and Daniel reacted
Quote
Share: